De. Aust et al., Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers, MOD PATHOL, 14(1), 2001, pp. 29-39
Citations number
45
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
The beta -catenin pathway plays a central role In transcriptional signaling
and cell-cell interactions in colonic epithelium. Alterations of the expre
ssion of beta -catenin, and its binding partners E-cadherin and the adenoma
tous polyposis coli protein (APC), are frequent events in sporadic colorect
al cancer. Ulcerative colitis (UC)-related cancers originate in a field of
chronic inflammation and therefore may have different alterations in the be
ta -catenin pathway than sporadic cancers. To test this hypothesis, express
ion and subcellular localization of beta -catenin, E-cadherin, and APC were
detected by immunohistochemistry in paraffin sections from 33 UC-related a
nd 42 sporadic colorectal cancers. Although beta -catenin and E-cadherin ex
pression were predominantly limited to the lateral cell membrane in normal
colonic epithelium, both tumor groups showed an overall shift from membrano
us to cytoplasmic expression for these proteins. An increase in nuclear loc
alization of beta -catenin and a decrease in cytoplasmic APC expression als
o were seen in both cancer groups compared with normal epithelium, Abnormal
beta -catenin expression was more closely linked to E-cadherin alterations
in UC-related cancers than in sporadic cancers. In contrast, abnormal beta
-catenin expression was more closely linked to APC alterations in sporadic
cancers than in UC-related cancers. These data suggest that alterations of
the beta -catenin pathway are important in both UC-related and sporadic co
lorectal cancers. However, differences in the expression patterns of beta -
catenin, E-cadherin, and APC between UC-related and sporadic colorectal can
cers suggest that the specific alterations in this pathway may differ in th
ese two cancer groups.